Literature DB >> 26148435

Arsenic-induced S phase cell cycle lengthening is associated with ROS generation, p53 signaling and CDC25A expression.

Glustein Pozo-Molina1, Alberto Ponciano-Gómez2, Guillermo Cipactl Rivera-González3, Araceli Hernández-Zavala4, Efraín Garrido5.   

Abstract

Cellular response to arsenic is strongly dependent on p53 functional status. Primarily arresting the cell cycle in G1 or G2/M phases, arsenic treatment also induces an increase in the S-phase time in wild-type p53 cells. In contrast, cells with a non-functional p53 display only a subtle increase in the S phase, indicating arsenic differentially affects the cell cycle depending on p53 status. Importantly, it has been reported that arsenic induces reactive oxygen species (ROS), a process counteracted by p53. To evaluate the participation of p53 in the lengthening of the S phase and the connection between the transient cell cycle arrest and oxidative stress, we evaluated the cell response to arsenic in MCF-7 and H1299 cells, and analyzed p53's role as a transcription factor in regulating genes involved in ROS reduction and S phase transition. Herein, we discovered that arsenic induced an increase in the population of S phase cells that was dependent on the presence and transcriptional activity of p53. Furthermore, for the first time, we demonstrate that arsenic activates p53-dependent transcription of ROS detoxification genes, such as SESN1, and by an indirect mechanism involving ATF3, genes that could be responsible for the S phase cell cycle arrest, such as CDC25A.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Arsenite; CDC25A; ROS; S phase lengthening; SESN1; p53

Mesh:

Substances:

Year:  2015        PMID: 26148435     DOI: 10.1016/j.cbi.2015.06.040

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  6 in total

1.  Cell cycle pathway dysregulation in human keratinocytes during chronic exposure to low arsenite.

Authors:  Laila Al-Eryani; Sabine Waigel; Venkatakrishna Jala; Samantha F Jenkins; J Christopher States
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-14       Impact factor: 4.219

2.  Monomethylarsonous acid, but not inorganic arsenic, is a mitochondria-specific toxicant in vascular smooth muscle cells.

Authors:  Clare Pace; Tania Das Banerjee; Barrett Welch; Roxana Khalili; Ruben K Dagda; Jeff Angermann
Journal:  Toxicol In Vitro       Date:  2016-06-17       Impact factor: 3.500

3.  Downregulation of Ubiquitin-conjugating Enzyme UBE2D3 Promotes Telomere Maintenance and Radioresistance of Eca-109 Human Esophageal Carcinoma Cells.

Authors:  Hui Yang; Lin Wu; Shaobo Ke; Wenbo Wang; Lei Yang; Xiaojia Gao; Hongyan Fang; Haijun Yu; Yahua Zhong; Conghua Xie; Fuxiang Zhou; Yunfeng Zhou
Journal:  J Cancer       Date:  2016-06-06       Impact factor: 4.207

Review 4.  Oncogenomic disruptions in arsenic-induced carcinogenesis.

Authors:  Adam P Sage; Brenda C Minatel; Kevin W Ng; Greg L Stewart; Trevor J B Dummer; Wan L Lam; Victor D Martinez
Journal:  Oncotarget       Date:  2017-04-11

5.  Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo.

Authors:  Bo Yuan; Mingjiang Yao; Xiao Wang; Ai Sato; Ayane Okazaki; Hana Komuro; Hideki Hayashi; Hiroo Toyoda; Xiaohua Pei; Xiaomei Hu; Toshihiko Hirano; Norio Takagi
Journal:  Cancer Cell Int       Date:  2018-08-13       Impact factor: 5.722

Review 6.  The Role of Reactive Oxygen Species in Arsenic Toxicity.

Authors:  Yuxin Hu; Jin Li; Bin Lou; Ruirui Wu; Gang Wang; Chunwei Lu; Huihui Wang; Jingbo Pi; Yuanyuan Xu
Journal:  Biomolecules       Date:  2020-02-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.